Skip to Main Content

A version of this story first appeared in STAT Health Tech, our weekly newsletter about how tech is transforming health care and the life sciences. Sign up here to receive it in your inbox.

For many ambitious health-tech startups, the holy grail is clear: landing a deal with a large biopharma company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!